logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 13
  • 1
    Diggle, Martin Henry
    Born in May 1962
    Individual (13 offsprings)
    Officer
    2021-02-19 ~ now
    OF - Director → CIF 0
  • 2
    Howlett, Brian
    Director born in March 1944
    Individual (19 offsprings)
    Officer
    2015-12-23 ~ 2024-03-31
    OF - Director → CIF 0
  • 3
    Mclean, Andrew, Dr
    Director born in May 1985
    Individual (15 offsprings)
    Officer
    2015-12-23 ~ 2018-07-25
    OF - Director → CIF 0
  • 4
    Taylor, Charles Richard
    Born in February 1959
    Individual (11 offsprings)
    Officer
    2020-01-01 ~ now
    OF - Director → CIF 0
  • 5
    Byrne, James Vincent, Professor
    Born in October 1950
    Individual (4 offsprings)
    Officer
    2015-12-23 ~ now
    OF - Director → CIF 0
  • 6
    Broadhurst, Ian Ronald
    Director born in April 1947
    Individual (6 offsprings)
    Officer
    2018-04-05 ~ 2019-04-24
    OF - Director → CIF 0
  • 7
    Feng, Xie
    Born in October 1984
    Individual (3 offsprings)
    Officer
    2015-12-23 ~ now
    OF - Director → CIF 0
  • 8
    Karim, Michael
    Ceo born in November 1966
    Individual (3 offsprings)
    Officer
    2015-09-09 ~ 2024-09-30
    OF - Director → CIF 0
  • 9
    Porter, Carolyn Breege, Dr
    Deputy Head Of Group Technology Transfer born in July 1970
    Individual (5 offsprings)
    Officer
    2015-12-23 ~ 2017-09-30
    OF - Director → CIF 0
  • 10
    PARKWALK ADVISORS LTD
    - now 06925696 OC345997
    PARK WALK ADVISORS LTD - 2015-12-01
    3, Pancras Square, London, United Kingdom
    Active Corporate (13 parents, 79 offsprings)
    Officer
    2019-04-24 ~ now
    OF - Director → CIF 0
    Person with significant control
    2024-04-09 ~ now
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    2024-01-23 ~ 2024-02-08
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 11
    OXFORD SCIENCE ENTERPRISES PLC - now
    OXFORD SCIENCES INNOVATION PLC
    - 2021-09-30 09093331 13564426
    OXFORD SCIENCES PLC - 2015-03-17
    The Weston Library, Broad Street, Oxford, United Kingdom
    Active Corporate (28 parents, 95 offsprings)
    Person with significant control
    2016-04-06 ~ 2021-03-30
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 12
    PENNSEC LIMITED
    - now 01751339
    ENFRANCHISE SECRETARIAL SERVICES LIMITED - 1992-02-04
    125, Wood Street, London, United Kingdom
    Active Corporate (27 parents, 823 offsprings)
    Officer
    2017-09-20 ~ now
    OF - Secretary → CIF 0
  • 13
    BLAKELAW SECRETARIES LIMITED
    - now 01914417
    SELLCO LIMITED - 1985-07-19
    Harbour Court, Compass Road, North Harbour, Portsmouth, Hampshire, United Kingdom
    Active Corporate (49 parents, 1279 offsprings)
    Officer
    2015-09-09 ~ 2017-09-05
    OF - Secretary → CIF 0
parent relation
Company in focus

OXFORD ENDOVASCULAR LIMITED

Period: 2015-09-09 ~ now
Company number: 09769779
Registered name
OXFORD ENDOVASCULAR LIMITED - now
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
92024-10-01 ~ 2025-09-30
62023-10-01 ~ 2024-09-30
Property, Plant & Equipment
62,500 GBP2025-09-30
1,340 GBP2024-09-30
Fixed Assets
62,500 GBP2025-09-30
1,340 GBP2024-09-30
Debtors
Current
632,781 GBP2025-09-30
535,137 GBP2024-09-30
Cash at bank and in hand
5,162,662 GBP2025-09-30
7,923,920 GBP2024-09-30
Current Assets
5,795,443 GBP2025-09-30
8,459,057 GBP2024-09-30
Creditors
Current, Amounts falling due within one year
-794,716 GBP2024-09-30
Net Current Assets/Liabilities
5,211,140 GBP2025-09-30
7,664,341 GBP2024-09-30
Total Assets Less Current Liabilities
5,273,640 GBP2025-09-30
7,665,681 GBP2024-09-30
Net Assets/Liabilities
5,273,640 GBP2025-09-30
7,665,681 GBP2024-09-30
Equity
Called up share capital
7,445 GBP2025-09-30
7,385 GBP2024-09-30
5,467 GBP2023-10-01
Share premium
19,926,538 GBP2025-09-30
19,926,538 GBP2024-09-30
12,187,075 GBP2023-10-01
Other miscellaneous reserve
1,405,011 GBP2025-09-30
1,232,802 GBP2024-09-30
1,052,489 GBP2023-10-01
Retained earnings (accumulated losses)
-16,065,354 GBP2025-09-30
-13,501,044 GBP2024-09-30
-10,564,724 GBP2023-10-01
Equity
5,273,640 GBP2025-09-30
7,665,681 GBP2024-09-30
2,680,307 GBP2023-10-01
Profit/Loss
Retained earnings (accumulated losses)
-2,564,310 GBP2024-10-01 ~ 2025-09-30
-2,936,320 GBP2023-10-01 ~ 2024-09-30
Profit/Loss
-2,564,310 GBP2024-10-01 ~ 2025-09-30
-2,936,320 GBP2023-10-01 ~ 2024-09-30
Issue of Equity Instruments
Called up share capital
60 GBP2024-10-01 ~ 2025-09-30
1,918 GBP2023-10-01 ~ 2024-09-30
Issue of Equity Instruments
60 GBP2024-10-01 ~ 2025-09-30
7,741,381 GBP2023-10-01 ~ 2024-09-30
Property, Plant & Equipment - Gross Cost
Office equipment
12,692 GBP2025-09-30
4,958 GBP2024-09-30
Computers
91,123 GBP2025-09-30
21,138 GBP2024-09-30
Property, Plant & Equipment - Gross Cost
103,815 GBP2025-09-30
26,096 GBP2024-09-30
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Office equipment
4,953 GBP2024-09-30
Computers
19,803 GBP2024-09-30
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
24,756 GBP2024-09-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Computers, Owned/Freehold
15,300 GBP2024-10-01 ~ 2025-09-30
Owned/Freehold
16,559 GBP2024-10-01 ~ 2025-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Office equipment
6,212 GBP2025-09-30
Computers
35,103 GBP2025-09-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
41,315 GBP2025-09-30
Property, Plant & Equipment
Office equipment
6,480 GBP2025-09-30
5 GBP2024-09-30
Computers
56,020 GBP2025-09-30
1,335 GBP2024-09-30
Other Debtors
Current
18,731 GBP2025-09-30
31,112 GBP2024-09-30
Prepayments/Accrued Income
Current
59,573 GBP2025-09-30
32,331 GBP2024-09-30
Amount of corporation tax that is recoverable
Current
521,483 GBP2025-09-30
452,739 GBP2024-09-30
Trade Creditors/Trade Payables
Current
44,001 GBP2025-09-30
102,752 GBP2024-09-30
Taxation/Social Security Payable
Current
29,380 GBP2025-09-30
107,248 GBP2024-09-30
Other Creditors
Current
12,236 GBP2025-09-30
92,982 GBP2024-09-30
Accrued Liabilities/Deferred Income
Current
47,697 GBP2025-09-30
40,745 GBP2024-09-30
Creditors
Current
584,303 GBP2025-09-30
794,716 GBP2024-09-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
744,453 shares2025-09-30
738,453 shares2024-09-30
Par Value of Share
Class 1 ordinary share
0.012024-10-01 ~ 2025-09-30

  • OXFORD ENDOVASCULAR LIMITED
    Info
    Registered number 09769779
    9400 Garsington Road, Oxford Business Park, Oxford OX4 2HN
    PRIVATE LIMITED COMPANY incorporated on 2015-09-09 (10 years 8 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-09-09
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.